ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Jacobio Pharmaceuticals Group Co., Ltd. ?
1
Weak Long Term Fundamental Strength with a 0.20% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -101.83
- The company has been able to generate a Return on Equity (avg) of 2.19% signifying low profitability per unit of shareholders funds
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 78.66%, its profits have risen by 55%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jacobio Pharmaceuticals Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jacobio Pharmaceuticals Group Co., Ltd.
-100.0%
3.43
93.72%
Hang Seng Hong Kong
8.25%
0.41
19.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
179.30%
EBIT Growth (5y)
0.20%
EBIT to Interest (avg)
-101.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.07
Sales to Capital Employed (avg)
0.13
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.93%
ROE (avg)
2.19%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.54
EV to EBIT
-22.78
EV to EBITDA
-25.93
EV to Capital Employed
-79.91
EV to Sales
31.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-17.51%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
ROCE(HY)
Highest at -5.08%
RAW MATERIAL COST(Y)
Fallen by -498.33% (YoY
PRE-TAX PROFIT(Q)
At HKD -64.41 MM has Grown at 64.8%
NET PROFIT(Q)
At HKD -64.41 MM has Grown at 64.8%
-4What is not working for the Company
INTEREST(Q)
Highest at HKD 8.51 MM
Here's what is working for Jacobio Pharmaceuticals Group Co., Ltd.
Pre-Tax Profit
At HKD -64.41 MM has Grown at 64.8%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD -64.41 MM has Grown at 64.8%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Raw Material Cost
Fallen by -498.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jacobio Pharmaceuticals Group Co., Ltd.
Interest
Highest at HKD 8.51 MM
in the last five periods and Increased by 147.75% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
